SCHEMBL18752348

SCHEMBL18752348

CCC(CC)NC(Cc1ccccc1)C(=O)NCC(=O)NC

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 9/20 0.46
▸ FCER2 P06734 3/20 0.46
▸ CTSS P25774 2/20 0.45
▸ CTSL P07711 1/20 0.45
▸ CTSB P07858 1/20 0.45
▸ CTSK P43235 1/20 0.44
▸ HDAC3 O15379 1/20 0.43
▸ HDAC4 P56524 1/20 0.43
▸ HDAC1 Q13547 1/20 0.43
▸ HDAC2 Q92769 1/20 0.43
▸ HDAC8 Q9BY41 1/20 0.43
▸ MMP2 P08253 9/20 0.43
▸ MMP3 P08254 8/20 0.43
▸ MMP7 P09237 7/20 0.43
▸ MMP9 P14780 3/20 0.43
▸ MMP8 P22894 3/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22199401 0.85 CTSS (0.50) MMP1FCER2CTSSCTSLCTSB
SCHEMBL22927776 0.81 CTSS (0.67) MMP1FCER2CTSSCTSLCTSB
SCHEMBL25976737 0.80 CTSS (0.55) MMP1FCER2CTSSCTSLCTSB
SCHEMBL25773989 0.80 CTSS (0.52) MMP1FCER2CTSSCTSLCTSB
SCHEMBL23380577 0.79 CTSS (0.57) CTSSCTSLCTSBCTSK
SCHEMBL20880680 0.78 CTSS (0.53) MMP1FCER2CTSSCTSLCTSB
SCHEMBL25751083 0.78 CTSS (0.50) MMP1FCER2CTSSCTSLCTSB
SCHEMBL19290000 0.77 HDAC3 (0.48) CTSSCTSKHDAC3HDAC4HDAC1
SCHEMBL18513842 0.77 CTSS (0.54) MMP1FCER2CTSSCTSLCTSB
SCHEMBL24380508 0.77 OPRD1 (0.53) MMP1FCER2CTSSCTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2753178-B1 PYRROLOBENZODIAZEPINES AND TARGETED CONJUGATES SEATTLE GENETICS INC (US) 2017-12-06 — — EP disclosed
EP-2751111-B1 Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases MEDIMMUNE LTD (GB) 2017-04-26 — — EP disclosed
EP-2751110-B1 Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative and autoimmune diseases MEDIMMUNE LTD (GB) 2017-04-19 — — EP disclosed
Send feedback